4021.T Nissan Chemical Corporation
JPXBasic MaterialsAs of 2026-08-07 15:30
Why 4021.T matters now
Nissan Chemical Corporation (4021.T) is a Japan stock in Basic Materials. The latest InvestLog snapshot shows ¥7,495.00 with -0.90% on the session and ¥1.01T in market capitalization.
Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E 20.35, gross margin 46.8%, and operating margin 22.7%.
Valuation
P/E (TTM)
20.35
PEG
—
P/B
3.96
P/S
3.60
EV/EBITDA
12.32
DCF Value
—
FCF Yield
4.5%
Div Yield
2.7%
Margins & Returns
Gross Margin
46.8%
Operating Margin
22.7%
Net Margin
17.8%
ROE
20.6%
ROA
14.0%
ROIC
16.0%
Listing Info
Market
Japan
Exchange
JPX
Currency
JPY
Sector
Basic Materials
Industry
Chemicals
Country
JP
Founded in Tokyo in 1887, Nissan Chemical Corporation conducts its diverse business operations both domestically in Japan and across international markets, specializing in four key areas: chemicals, performance materials, agricultural chemicals, and pharmaceuticals. The company's expansive chemical product line includes the adhesive agent MELAMINE, a variety of high-purity chemicals, the urea solution AdBlue, and foundational industrial compounds such as ammonia, sulfuric acid, and nitric acid. Other specialized chemical offerings feature TEPIC (an epoxy compound), Melamine Cyanurate (a salt of melamine and isocyanuric acid), phenylphosphonic acid, and HI-LITE (a chlorinated isocyanurate). Additionally, Nissan Chemical manufactures the health food Nissan Reishi, OPTBEADS (composed of melamine-formaldehyde resin and silica), and FINEOXOCOL (a saturated fatty alcohol and acid). Within its performance materials division, the corporation develops crucial materials for display technologies, semiconductors, and various inorganic applications. Its agricultural chemicals segment supplies a broad range of products, including herbicides, insecticides, and fungicides, utilized on farmlands, golf courses, and public parks. This division also produces active pharmaceutical ingredients for animal antiparasitic medications. In the pharmaceutical sector, Nissan Chemical markets prescription drugs such as LIVALO, which is used to reduce cholesterol, and LANDEL and FINTE, both dual-action calcium channel blockers. Beyond its proprietary pharmaceutical products, the company offers custom manufacturing and process research services for pharmaceutical ingredients. Looking towards future innovation, Nissan Chemical is actively engaged in developing solutions across healthcare, information and communication materials, and environmental and energy materials. The company, which was previously known as Nissan Chemical Industries, Ltd., officially changed its name to Nissan Chemical Corporation in July 2018.